Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection

NCT02249546 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

654

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: N-acetylcysteine + PPI-amoxicillin-clarithromycin
DRUG: PPI-amoxicillin-clarithromycin

Sponsor

National Taiwan University Hospital